Medtronic plc Stock

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:57:20 2024-05-23 pm EDT 5-day change 1st Jan Change
81.3 USD -5.19% Intraday chart for Medtronic plc -4.44% -0.66%
Sales 2024 32.36B Sales 2025 * 33.55B Capitalization 114B
Net income 2024 3.68B Net income 2025 * 5.24B EV / Sales 2024 * 4.22 x
Net Debt 2024 * 22.21B Net Debt 2025 * 21.12B EV / Sales 2025 * 4.02 x
P/E ratio 2024 *
24.4 x
P/E ratio 2025 *
21.2 x
Employees 95,000
Yield 2024 *
3.21%
Yield 2025 *
3.37%
Free-Float 99.78%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.60%
1 week-4.17%
Current month+2.27%
1 month+0.95%
3 months-4.21%
6 months+3.92%
Current year-0.38%
More quotes
1 week
81.82
Extreme 81.82
86.17
1 month
78.78
Extreme 78.78
86.17
Current year
78.43
Extreme 78.43
89.18
1 year
68.84
Extreme 68.84
91.00
3 years
68.84
Extreme 68.84
135.89
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 15-01-25
Director of Finance/CFO 58 16-05-31
Chief Operating Officer 63 21-03-31
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 70 06-12-31
Director/Board Member 68 14-12-31
More insiders
Date Price Change Volume
24-05-23 81.74 -4.69% 8 332 792
24-05-22 85.76 +0.69% 8,527,853
24-05-21 85.17 +0.78% 4,131,608
24-05-20 84.51 -1.64% 5,513,007
24-05-17 85.92 +0.33% 8,236,275

Delayed Quote Nyse, May 23, 2024 at 03:30 pm EDT

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
85.76 USD
Average target price
94.77 USD
Spread / Average Target
+10.51%
Consensus